ClinicalTrials.Veeva

Menu
M

Multiprofile Hospital for Active Treatment Puls | Clinical Trial Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

EDP-938
Caspofungin
Milvexian
Rezafungin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 3 total trials
Locations recently updated

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

Trial sponsors

C
Enanta Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems